Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Launched by UNIVERSITY OF BRITISH COLUMBIA · Dec 1, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a type of surgery called nerve transfer surgery to see if it can help people with cervical spinal cord injuries regain better use of their arms and hands. The study will compare the results of individuals who have had this surgery with those who have not, to understand how effective the surgery is for improving movement and function in the upper limbs. Researchers aim to develop a way to predict how well someone might do after the surgery based on their health and physical condition before the operation.
To participate in this study, you need to be between 18 and 80 years old and have a complete or almost complete spinal cord injury at the C5 to C8 level. You should be able to give consent and speak or understand English. However, if you have certain medical issues that are not under control or have received specific treatments for muscle tone in your arms, you may not be eligible. If you join the study, you can expect to undergo testing and assessments before and after the surgery, and you will receive rehabilitation support to help with your recovery. This trial is currently recruiting participants, and everyone is welcome to apply.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Motor complete (AIS A or B) between neurological level of injury C5 and C8
- • Able to provide informed written consent
- • Able to attend and comply with the testing protocols
- • Able to understand and speak English or have access to an appropriate interpreter as judged by the investigator.
- Exclusion Criteria:
- • An uncontrolled medical condition (e.g. uncontrolled cardiovascular disease, diabetes, kidney or liver disease)
- • Have ever received botulinum toxin injections (Botox) for tone management in the upper limb
- • An unmanaged secondary complication of SCI including but not limited to uncontrolled neuropathic pain or spasticity, syringomyelia, fracture, urinary tract infection or significant pressure ulcer, preventing participation in testing
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Halifax, Nova Scotia, Canada
Kingston, Ontario, Canada
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Michael Berger, MD, PHD
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials